Huang Xiao, Zhou Minwei, Li Zhenyang, Zhao Ziheng, Zhou Yiming, Zang Yiwen, Yang Yi, Wang Zihao, Chen Zongyou, Gu Xiaodong, Zhang Jian, Xiang Jianbin
Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Department of General Surgery, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.
J Gastrointest Oncol. 2023 Jun 30;14(3):1293-1306. doi: 10.21037/jgo-22-995. Epub 2023 Apr 20.
Postoperative recurrence was a life-threatening condition for patients with rectal cancer. Due to the heterogeneity of locally recurrent rectal cancer (LRRC) and controversy of the optimal treatment for patients, it was difficult to predict the prognosis of LRRC. This study aimed to develop and validate a nomogram that could accurately predict the survival probability of LRRC.
Patients diagnosed with LRRC between 2004 and 2019 from the Surveillance, Epidemiology, and End Results (SEER) database were included in the analysis. Multiple imputations with chained equations were used for missing values. These patients were further randomized into training set and testing set. Cox regression was used for univariate and multivariate analysis. Potential predictors were screened by the least absolute shrinkage and selection operator (LASSO). The Cox hazards regression model was constructed and it was visualized by nomogram. C-index, calibration curve, and decision curve were used to evaluate the model's predictive ability. Then X-tile was used to calculate the optimal cut-off values for all patients and the cohort was divided into three groups.
A total of 744 LRRC patients were enrolled and allocated to the training set (n=503) and the testing set (n=241). Cox regression analysis of the training set yielded meaningfully clinicopathological variables. A survival nomogram was created based on the identification of ten clinicopathological features in the LASSO regression analyses of the training set. The C-index of 3-, 5-year survival probabilities were 0.756, 0.747 in training set, and 0.719, 0.726 in testing set, respectively. The calibration curve and decision curve both demonstrated the satisfactory performance of the nomogram for prognosis prediction. Moreover, the prognosis of LRRC could be well distinguished according to the grouping of risk scores (P<0.001 in three groups).
This nomogram was the first prediction model to preliminarily evaluate the survival of LRRC patients, which could provide more accurate and efficient treatment in clinical practice.
术后复发对直肠癌患者来说是一种危及生命的情况。由于局部复发性直肠癌(LRRC)的异质性以及针对患者的最佳治疗方法存在争议,因此很难预测LRRC的预后。本研究旨在开发并验证一种能准确预测LRRC生存概率的列线图。
分析纳入了2004年至2019年期间来自监测、流行病学和最终结果(SEER)数据库中诊断为LRRC的患者。采用链式方程多重填补法处理缺失值。这些患者被进一步随机分为训练集和测试集。采用Cox回归进行单因素和多因素分析。通过最小绝对收缩和选择算子(LASSO)筛选潜在预测因素。构建Cox风险回归模型并用列线图进行可视化展示。使用C指数、校准曲线和决策曲线评估模型的预测能力。然后使用X-tile计算所有患者的最佳截断值,并将队列分为三组。
共纳入744例LRRC患者,并分配至训练集(n = 503)和测试集(n = 241)。训练集的Cox回归分析得出了有意义的临床病理变量。基于训练集LASSO回归分析中识别出的十个临床病理特征创建了生存列线图。训练集中3年、5年生存概率的C指数分别为0.756、0.747,测试集中分别为0.719、0.726。校准曲线和决策曲线均显示列线图在预后预测方面表现良好。此外,根据风险评分分组可以很好地区分LRRC的预后(三组P < 0.001)。
该列线图是首个初步评估LRRC患者生存情况的预测模型,可为临床实践提供更准确、高效的治疗依据。